[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DD145267A5 - Verfahren zur herstellung n-substituierter aziridin-2-carbonsaeurederivate - Google Patents

Verfahren zur herstellung n-substituierter aziridin-2-carbonsaeurederivate Download PDF

Info

Publication number
DD145267A5
DD145267A5 DD79214711A DD21471179A DD145267A5 DD 145267 A5 DD145267 A5 DD 145267A5 DD 79214711 A DD79214711 A DD 79214711A DD 21471179 A DD21471179 A DD 21471179A DD 145267 A5 DD145267 A5 DD 145267A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
cyano
aziridine
group
compound
Prior art date
Application number
DD79214711A
Other languages
German (de)
English (en)
Inventor
Elmar Bosies
Herbert Berger
Wolfgang Kampe
Uwe Bicker
Alfred Grafe
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DD145267A5 publication Critical patent/DD145267A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD79214711A 1978-08-03 1979-07-31 Verfahren zur herstellung n-substituierter aziridin-2-carbonsaeurederivate DD145267A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782833986 DE2833986A1 (de) 1978-08-03 1978-08-03 Immunstimulierende n-substituierte aziridin-2-carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese substanzen enthalten

Publications (1)

Publication Number Publication Date
DD145267A5 true DD145267A5 (de) 1980-12-03

Family

ID=6046078

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79214711A DD145267A5 (de) 1978-08-03 1979-07-31 Verfahren zur herstellung n-substituierter aziridin-2-carbonsaeurederivate

Country Status (39)

Country Link
US (3) US4321194A (es)
JP (2) JPS5522694A (es)
KR (1) KR860000320B1 (es)
AR (1) AR228945A1 (es)
AT (1) AT379382B (es)
AU (1) AU524572B2 (es)
BE (1) BE878020A (es)
CA (1) CA1142530A (es)
CH (1) CH645540A5 (es)
CS (1) CS227301B2 (es)
DD (1) DD145267A5 (es)
DE (1) DE2833986A1 (es)
DK (1) DK156431C (es)
EG (1) EG14369A (es)
ES (1) ES483116A1 (es)
FI (1) FI70570C (es)
FR (2) FR2432317A1 (es)
GB (2) GB2026863B (es)
GR (1) GR74424B (es)
HK (1) HK13285A (es)
HU (1) HU184610B (es)
IE (1) IE48462B1 (es)
IL (1) IL57939A (es)
IT (1) IT1123503B (es)
KE (1) KE3493A (es)
LU (1) LU81563A1 (es)
MY (1) MY8600045A (es)
NL (1) NL187239C (es)
NO (1) NO152413C (es)
NZ (1) NZ191169A (es)
OA (1) OA06310A (es)
PH (1) PH19007A (es)
PL (1) PL126531B1 (es)
PT (1) PT70009A (es)
SE (1) SE445552B (es)
SG (1) SG85784G (es)
SU (1) SU1145927A3 (es)
YU (1) YU41169B (es)
ZA (1) ZA793966B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3446713A1 (de) * 1984-12-21 1986-06-26 Boehringer Mannheim Gmbh, 6800 Mannheim N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel
JPS6287512A (ja) * 1985-10-11 1987-04-22 ベ−リンガ−・マンハイム・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 選択的免疫抑制剤
US4925835A (en) * 1986-05-01 1990-05-15 Sloan-Kettering Institute For Cancer Research Aziridinyl putrescine containing compositions and their uses in treating prostate cancer
KR19980083844A (ko) * 1997-05-19 1998-12-05 이웅열 새로운 아지리딘 유도체 및 그 제조방법
FR2776292B1 (fr) * 1998-03-20 2004-09-10 Oncopharm Cephalotaxanes porteurs de chaine laterale et leur procede de synthese
KR20010000195A (ko) * 2000-08-10 2001-01-05 하현준 (2ｒ)- 및 (2ｓ)-아지리딘-2-카르복실산 에스테르 및(2ｒ)- 및 (2ｓ)-2-히드록시메틸 아지리딘 제조 방법
CA2431947A1 (en) * 2000-11-21 2002-05-30 Gabriel Lopez-Berestein Composition comprising an imexon or derivatives thereof and lipids
US20030129222A1 (en) * 2000-11-21 2003-07-10 Gabriel Lopez-Berestein Liposomal imexon
US6982263B2 (en) * 2001-06-08 2006-01-03 Boehringer Ingelheim Pharmaceuticals, Inc. Nitriles useful as reversible inhibitors of cysteine proteases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470223A1 (de) * 1962-09-05 1969-12-04 Siegfried Ag Verfahren zur Herstellung neuer stickstoffhaltiger Heterocyclen
DE2528460A1 (de) * 1975-06-26 1977-01-13 Boehringer Mannheim Gmbh Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
DE2530960A1 (de) 1975-07-11 1977-01-27 Huels Chemische Werke Ag 2-(n-substituierte)-aziridinyl-delta hoch 2 -oxazoline und verfahren zu ihrer herstellung
DE2538672A1 (de) * 1975-08-30 1977-03-10 Boehringer Mannheim Gmbh Verwendung von derivaten der propionsaeure
DE2656240C2 (de) * 1976-12-11 1983-11-03 Boehringer Mannheim Gmbh, 6800 Mannheim Neue Aziridin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Mittel
CA1092606A (en) * 1976-10-05 1980-12-30 Herbert Berger 1-(n-acylcarbamoyl)-2-cyano-aziridines and the preparation thereof
GB1550065A (en) * 1976-10-29 1979-08-08 Inst Organicheskogo Sinteza Ak Pharmaceutical composition processing antitumour activity
AR218645A1 (es) * 1976-12-11 1980-06-30 Boehringer Mannheim Gmbh Procedimiento para preparar derivados de esteres del acido 1-aziridina-carboxilico

Also Published As

Publication number Publication date
PT70009A (de) 1979-08-01
FI70570C (fi) 1986-09-24
FR2432317A1 (fr) 1980-02-29
IT7924769A0 (it) 1979-07-30
DK156431B (da) 1989-08-21
MY8600045A (en) 1986-12-31
IE48462B1 (en) 1985-01-23
YU41169B (en) 1986-12-31
JPH0257523B2 (es) 1990-12-05
LU81563A1 (de) 1980-08-08
NO152413C (no) 1985-09-25
JPS63258415A (ja) 1988-10-25
IE791478L (en) 1980-02-03
GB2026863A (en) 1980-02-13
NO152413B (no) 1985-06-17
HU184610B (en) 1984-09-28
OA06310A (fr) 1981-06-30
ES483116A1 (es) 1980-04-16
KE3493A (en) 1985-02-01
IL57939A0 (en) 1979-11-30
IL57939A (en) 1985-02-28
PL126531B1 (en) 1983-08-31
CA1142530A (en) 1983-03-08
DK156431C (da) 1990-01-22
FI792393A (fi) 1980-02-04
SG85784G (en) 1985-06-07
IT1123503B (it) 1986-04-30
US4409236A (en) 1983-10-11
EG14369A (en) 1983-12-31
ATA531479A (de) 1985-05-15
DE2833986A1 (de) 1980-02-21
SU1145927A3 (ru) 1985-03-15
NO792545L (no) 1980-02-05
YU188179A (en) 1983-06-30
FR2445316B1 (es) 1983-07-29
GR74424B (es) 1984-06-28
KR830000902A (ko) 1983-04-28
NL187239C (nl) 1991-07-16
DK320379A (da) 1980-02-04
JPS5522694A (en) 1980-02-18
GB2106896B (en) 1983-08-17
GB2026863B (en) 1983-03-30
FR2445316A1 (fr) 1980-07-25
AR228945A1 (es) 1983-05-13
US4321194A (en) 1982-03-23
JPS6243991B2 (es) 1987-09-17
FR2432317B1 (es) 1983-03-18
DE2833986C2 (es) 1988-04-07
KR860000320B1 (ko) 1986-04-09
GB2106896A (en) 1983-04-20
FI70570B (fi) 1986-06-06
PH19007A (en) 1985-12-03
CH645540A5 (de) 1984-10-15
HK13285A (en) 1985-03-01
ZA793966B (en) 1980-08-27
US4410532A (en) 1983-10-18
SE7906461L (sv) 1980-02-04
SE445552B (sv) 1986-06-30
PL217527A1 (es) 1980-07-01
NL7905855A (nl) 1980-02-05
AU524572B2 (en) 1982-09-23
AU4930879A (en) 1980-02-07
BE878020A (fr) 1980-02-01
AT379382B (de) 1985-12-27
CS227301B2 (en) 1984-04-16
NZ191169A (en) 1981-01-23

Similar Documents

Publication Publication Date Title
EP0014976B1 (de) N-substituierte 2-Cyanaziridine, Verfahren zu deren Herstellung sowie diese Substanzen enthaltende Arzneimittel, entsprechend substituierte Aziridin-2-carbonsäureamide und deren Herstellung
DE2332878C2 (de) Salze von Cephalosporinen mit Arginin und Lysin, ihre Herstellung und injizierbare pharmazeutische Zubereitungen
DE2928485A1 (de) Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
DD145267A5 (de) Verfahren zur herstellung n-substituierter aziridin-2-carbonsaeurederivate
DE2319278C2 (de) Pharmazeutisches Mittel
EP0104423A1 (de) 2-Nitro-1,1-ethendiamine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE3035688C2 (es)
CH629779A5 (de) Verfahren zur herstellung von benzolsulfonylharnstoffen.
AT390437B (de) Tromethamin-salz von 1-methyl-beta-oxo-alpha(phenylcarbamoyl)-2-pyrrol-propionitril
DE2236876C3 (de) N-Substituierte Aminocarbonsäuren und diese Verbindungen enthaltende Arzneimittel
DE3004348C2 (es)
EP0000336B1 (de) Amidino-benzylpyrimidine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0280290B1 (de) Mittel mit antidepressiver Wirkung
DE2858177C2 (de) Arzneimittel enthaltend N-substituierte 2-Cyanaziridine
DE3806633A1 (de) Antivirales mittel
EP0049538A2 (de) Verwendung von Thioharnstoffderivaten als Arzneimittel bei der Behandlung von Fettstoffwechselstörungen
DE4021006A1 (de) Pyrimidin-derivate, deren herstellung und verwendung sowie diese enthaltende arzneimittel
EP0150719B1 (de) Substituierte Salicylsäureamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
AT386195B (de) Verfahren zur herstellung von neuen n-substituierten aziridin-2-carbonsaeurederivaten und ihren salzen
EP0000335A1 (de) N-Pyrimidinyl-imidsäureester, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel.
EP0167945A2 (de) Phenylethylaminopropiophenon-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2948832A1 (de) 1-sulfenylaziridin-2-carbonsaeurederivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2365378C2 (es)
DE2017902C3 (de) Benzothiopyranverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2843008A1 (de) 5(6)-eckige klammer auf (cyclopropylethyl)-sulphinyl eckige klammer zu -benzimidazol-2-methylcarbamat, ein verfahren zu seiner herstellung, sowie pharmazeutische zusammensetzung